tiprankstipranks
Advertisement
Advertisement

Vireo Growth Closes Transformative Acquisition of Eaze Inc.

Story Highlights
  • Vireo Growth closed its all-share acquisition of Eaze, issuing roughly 90 million shares and RSUs while adding major California, Colorado and Florida retail and delivery scale.
  • Vireo also restructured its New York subsidiary with Ace Venture holding 51%, Vireo retaining economic priority and a $16 million note to align with state equity licensing rules.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Vireo Growth Closes Transformative Acquisition of Eaze Inc.

Claim 30% Off TipRanks

An update from Vireo Growth ( (TSE:VREO) ) is now available.

On April 1, 2026, Vireo Growth closed its acquisition of Eaze Inc., a vertically integrated cannabis retailer and delivery technology platform with 67 retail locations across California, Colorado and Florida and more than 12 million completed deliveries. The all-share transaction, governed by an amended merger agreement, saw Vireo issue about 90.4 million subordinate voting shares as estimated closing consideration, structure additional earnout payments in stock tied to 2026 EBITDA, and grant closing and incentive RSUs to key Eaze employees.

Former Eaze shareholders received a portion of the shares at closing, with the balance placed in escrow and subject to post‑closing price adjustments, while all merger shares are subject to staged lock‑ups through March 2028 alongside piggyback resale rights. The deal immediately adds 15 dispensaries to Vireo’s Colorado footprint, establishes a substantial retail and delivery presence in California and Florida, and installs Eaze CEO Cory Azzalino as head of Vireo’s California business, materially expanding Vireo’s scale and competitive position in major U.S. cannabis markets.

Separately, on March 31, 2026, Vireo restructured its New York operations by amending the operating agreement for Vireo Health of New York LLC to support qualification as a social and economic equity licensee. Under the new structure, partner Ace Venture of NY holds 51% of VHNY’s membership interests, Vireo’s subsidiary retains 49% along with priority cash‑distribution rights, and VHNY issued a $16 million intercompany note to Vireo Health, aligning ownership, governance and funding with evolving New York cannabis regulations.

More about Vireo Growth

Vireo Growth Inc. is a U.S.-based cannabis operator founded in 2014, building a vertically integrated platform spanning cultivation, production, retail and delivery. The company focuses on disciplined expansion and local market execution, and following the Eaze deal will operate in 10 states with more than 160 dispensaries and roughly 800,000 square feet of cultivation and production capacity.

YTD Price Performance: -33.73%

Average Trading Volume: 45,564

Technical Sentiment Signal: Strong Sell

Current Market Cap: C$594.2M

For detailed information about VREO stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1